Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Michelangelo Or Ilimb Ultra Multigrip Myoelectric Prosthesis

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Early Phase 1 (1)

Trial Status

Recruiting2
Withdrawn1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07876115Not ApplicableRecruiting

Cross-Over Study Evaluating the TASKA GEN2 Myoelectric Hand Prosthesis

NCT06853938Not ApplicableRecruitingPrimary

Optimizing Transhumeral Osseointegration Prosthesis Control

NCT03824444Early Phase 1WithdrawnPrimary

EFS Functional Expectations of Transhumeral Percutaneous OI Patients

NCT01932892CompletedPrimary

Quantifying Prosthetic Socket Interface Movement

Showing all 4 trials

Research Network

Common Treatments

  • Michelangelo Or Ilimb Ultra Multigrip Myoelectric Prosthesis1
  • Myoelectric Prosthesis1
  • Pods1
  • Taska Gen2 Multigrip Myoelectric Hand Prosthesis1

Active Sponsors

  • TASKA Prosthetics1
  • University of Alberta1
  • VA Office of Research and Development1
  • University of South Florida1

Top Investigators

Related Conditions

  • Transradial Amputation1
  • Upper Limb Amputation1

Activity Timeline